Treatment of refractory chronic lymphocytic leukemia may include the following:

• A clinical trial of chemotherapy with stem cell transplant.
• A clinical trial of a new treatment.

This summary section refers to specific treatments under study in clinical trials, but it may not mention every new treatment being studied. Information about ongoing clinical trials is available from the NCI Web site.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with refractory chronic lymphocytic leukemia.

Back to Top

< Previous Section  |  Next Section >